Astrazeneca Pharma India surges on delisting proposal

Shares in Astrazeneca Pharma India Ltd surge 20 percent to their maximum daily limit after the drug maker says its board would meet on Wednesday to discuss delisting proposal.

AstraZeneca Pharma India said in the filing before markets opened on Monday that its board received a request from its promoter, AstraZeneca Pharmaceuticals AB Sweden, to initiate a voluntary delisting process.

Astrazeneca Pharmaceuticals AB holds 75 percent in AstraZeneca Pharma India.


  • India’s economic recovery has to be consumption, and not investment, led

    It is well accepted that falling global commodity prices, especially oil, have helped the Indian economy regain lustre in the past year or so.


Stay informed on our latest news!


Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs


Amita Sharma

Smart cities for the smart citizens

The 21st century has been spoken of as the urban ...

Purnendu Ghosh

Too shy people love themselves too much

We are essentially shy people. Our extent of shyness, however, ...

Shona Adhikari

When nature and naturism have a date

DAG Modern has announced its forthcoming exhibition The Naked and ...


William D. Green

Chairman & CEO, Accenture